SEC EDGAR · Insider purchase
NXTC: ADAR1 Capital Management, LLC; Schneeberger Daniel reported buying shares
1 reported purchase of non-derivative securities. Code P includes open-market and private purchases; it does not establish motive.
Follow NXTC- Became public
- Nov 13, 2026, 4:00 PM EST
- Event / period date
- Nov 11, 2026
- Collected
- Nov 13, 2026, 4:06 PM EST
Why this is connected
This filing identifies NextCure, Inc. as the issuer of the security. The company's SEC identifier connects it to NXTC.
Reported transactions
ADAR1 Capital Management, LLC (10% owner); Schneeberger Daniel (10% owner)
12,333 shares · Common Stock
Nov 11, 2026 · $5.0999 per share
Value calculated from the reported shares and prices: $62,897.07.
Code P covers open-market and private purchases. Grants, option exercises, and tax withholding are excluded from purchase results. Read the source footnotes for ownership and pricing details.
Source evidence
Read the source excerpt or record
<?xml version="1.0"?>
<ownershipDocument>
<schemaVersion>X0609</schemaVersion>
<documentType>4</documentType>
<periodOfReport>2026-11-11</periodOfReport>
<notSubjectToSection16>0</notSubjectToSection16>
<issuer>
<issuerCik>0001661059</issuerCik>
<issuerName>NextCure, Inc.</issuerName>
<issuerTradingSymbol>NXTC</issuerTradingSymbol>
</issuer>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001940272</rptOwnerCik>
<rptOwnerName>ADAR1 Capital Management, LLC</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>3503 WILD CHERRY DRIVE</rptOwnerStreet1>
<rptOwnerStreet2>BUILDING 9</rptOwnerStreet2>
<rptOwnerCity>AUSTIN</rptOwnerCity>
<rptOwnerState>TX</rptOwnerState>
<rptOwnerZipCode>78738</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<reportingOwner>
<reportingOwnerId>
<rptOwnerCik>0001861120</rptOwnerCik>
<rptOwnerName>Schneeberger Daniel</rptOwnerName>
</reportingOwnerId>
<reportingOwnerAddress>
<rptOwnerNonUSAddressFlag>false</rptOwnerNonUSAddressFlag>
<rptOwnerStreet1>3503 WILD CHERRY DRIVE, BUILDING 9</rptOwnerStreet1>
<rptOwnerStreet2></rptOwnerStreet2>
<rptOwnerCity>AUSTIN</rptOwnerCity>
<rptOwnerState>TX</rptOwnerState>
<rptOwnerZipCode>78738</rptOwnerZipCode>
<rptOwnerStateDescription></rptOwnerStateDescription>
</reportingOwnerAddress>
<reportingOwnerRelationship>
<isDirector>0</isDirector>
<isOfficer>0</isOfficer>
<isTenPercentOwner>1</isTenPercentOwner>
<isOther>0</isOther>
</reportingOwnerRelationship>
</reportingOwner>
<aff10b5One>0</aff10b5One>
<nonDerivativeTable>
<nonDerivativeTransaction>
<securityTitle>
<value>Common Stock</value>
</securityTitle>
<transactionDate>
<value>2026-11-11</value>
</transactionDate>
<transactionCoding>
<transactionFormType>4</transactionFormType>
<transactionCode>P</transactionCode>
<equitySwapInvolved>0</equitySwapInvolved>
</transactionCoding>
<transactionTimeliness>
<value></value>
</transactionTimeliness>
<transactionAmounts>
<transactionShares>
<value>12333</value>
</transactionShares>
<transactionPricePerShare>
<value>5.0999</value>
<footnoteId id="F1"/>
</transactionPricePerShare>
<transactionAcquiredDisposedCode>
<value>A</value>
</transactionAcquiredDisposedCode>
</transactionAmounts>
<postTransactionAmounts>
<sharesOwnedFollowingTransaction>
<value>750289</value>
</sharesOwnedFollowingTransaction>
</postTransactionAmounts>
<ownershipNature>
<directOrIndirectOwnership>
<value>I</value>
</directOrIndirectOwnership>
<natureOfOwnership>
<value>See Footnote</value>
<footnoteId id="F2"/>
<footnoteId id="F3"/>
</natureOfOwnership>
</ownershipNature>
</nonDerivativeTransaction>
</nonDerivativeTable>
<footnotes>
<footnote id="F1">The reported price is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $5.0750 to $5.1000, inclusive. Each Reporting Person undertakes to provide to NextCure, Inc., any security holder of NextCure, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in this footnote.</footnote>
<footnote id="F2">The reported securities are owned directly by private investment funds managed by ADAR1 Capital Management, LLC, and may be deemed to be indirectly beneficially owned by (i) ADAR1 Capital Management, LLC and (ii) Daniel Schneeberger, the sole manager of ADAR1 Capital Management, LLC.</footnote>
<footnote id="F3">For purposes of Section 16 of the Securities Exchange Act of 1934, as amended, each Reporting Person disclaims beneficial ownership of any such securities, except to the extent of his/its pecuniary interest therein, if any, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of such securities for purposes of Section 16 or otherwise.</footnote>
</footnotes>
<ownerSignature>
<signatureName>ADAR1 Capital Management, LLC By: Daniel Schneeberger, Manager /s/ Daniel Schneeberger</signatureName>
<signatureDate>2026-11-11</signatureDate>
</ownerSignature>
<ownerSignature>
<signatureName>/s/ Daniel Schneeberger</signatureName>
<signatureDate>2026-11-11</signatureDate>
</ownerSignature>
</ownershipDocument>Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.